Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Updates Plavix Label, Leaves Effient With Clear Advantage

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA expands upon the warning that it discreetly slipped into the anti-clotting drug's labeling in May, with new data that clopidogrel is 50% less effective when given with Prilosec.
Advertisement

Related Content

AstraZeneca Submits Brilinta To FDA, But Review Could Be Lengthy
Best of the Blog, IN VIVO, November 2009
Best of the Blog, IN VIVO, November 2009
AstraZeneca Submits Brilinta To FDA, But Review Could Be Lengthy
AstraZeneca Submits Brilinta To FDA, But Review Could Be Lengthy
Quality By Design Pilot Found Unprecedented Manufacturing Quirk For Effient
Does TRITON Really Show If Effient Was Better Than Plavix?
"Silent" MIs Outweigh "Scary" Bleeds, FDA Concludes In Effient Review
Plavix Pharmacogenomic Label Update May Help Lilly With Effient Launch
Plavix Pharmacogenomic Label Update May Help Lilly With Effient Launch

Topics

Advertisement
UsernamePublicRestriction

Register

PS068758

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel